J Michael Straughn
Overview
Explore the profile of J Michael Straughn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown S, Roane B, Caridi T, Straughn J, Gunn A
Abdom Radiol (NY)
. 2023 May;
48(7):2443-2448.
PMID: 37145314
Purpose: To evaluate the outcomes of uterine artery embolization (UAE) for patients with urgent or emergent abnormal uterine bleeding (AUB). Materials And Methods: Retrospective review of all patients from 1/2009-12/2020...
2.
3.
Boitano T, Ketch P, Maier J, Nguyen C, Huh W, Straughn J, et al.
Gynecol Oncol Rep
. 2022 Jul;
42:101041.
PMID: 35898199
Background: To determine whether race and ethnicity impacts patient adherence to follow-up for colposcopy after abnormal cervical cancer screening. Methods: This retrospective chart review included women that were randomly selected...
4.
Modesitt S, Havrilesky L, Previs R, Rauh-Hain J, Straughn J, Bakkum-Gamez J, et al.
Gynecol Oncol Rep
. 2022 Jun;
42:101024.
PMID: 35719321
No abstract available.
5.
Dholakia J, Cohn D, Straughn J, Dilley S
J Gynecol Oncol
. 2021 Oct;
32(6):e92.
PMID: 34708594
Objective: To assess the potential cost-effectiveness of prehabilitation in medically frail patients undergoing surgery for epithelial ovarian cancer (EOC). Methods: We created a cost-effectiveness model evaluating the impact of prehabilitation...
6.
Boitano T, Sanders L, Gentry Z, Smith H, Leath C, Xhaja A, et al.
Gynecol Oncol
. 2020 Sep;
159(3):773-777.
PMID: 32951895
Objective: The objective of this study was to evaluate the impact of a post-surgical restrictive opioid prescribing algorithm (ROPA) in gynecologic oncology patients. Methods: This cohort study included gynecologic oncology...
7.
Smith H, Straughn J, Buchsbaum D, Arend R
Gynecol Oncol Rep
. 2017 Apr;
20:81-86.
PMID: 28378010
Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease. The introduction of targeted therapies to traditional...
8.
Walters Haygood C, Fauci J, Huddleston-Colburn M, Huh W, Straughn J
J Robot Surg
. 2016 Sep;
8(3):207-11.
PMID: 27637679
This study evaluated intraoperative complications and postoperative outcomes of gynecologic oncology patients undergoing robotic-assisted (RA) laparoscopic procedures in a university setting. A retrospective chart review evaluated all gynecologic oncology patients...
9.
Walters Haygood C, Arend R, Straughn J, Buchsbaum D
World J Stem Cells
. 2014 Sep;
6(4):441-7.
PMID: 25258665
Despite significant effort and research funds, epithelial ovarian cancer remains a very deadly disease. There are no effective screening methods that discover early stage disease; the majority of patients are...
10.
Arend R, Londono-Joshi A, Samant R, Li Y, Conner M, Hidalgo B, et al.
Gynecol Oncol
. 2014 Apr;
134(1):112-20.
PMID: 24736023
Objective. The Wnt/β-catenin pathway is known to regulate cellular proliferation and plays a role in chemoresistance. Niclosamide, an FDA approved salicyclamide derivative used for the treatment of tapeworm infections, targets...